To access architecturally complex natural products, chemists usually devise a customized synthetic strategy for constructing a single target skeleton. In contrast, biosynthetic assembly lines often employ divergent intramolecular cyclizations of a polyunsaturated common intermediate to produce diverse arrays of scaffolds. With the aim of integrating such biogenetic strategies, here we show the development of an artificial divergent assembly line generating unprecedented numbers of scaffold variations of terpenoid indole alkaloids. This approach allows not only practical access to multipotent intermediates but also systematic diversification of skeletal, stereochemical, and functional group properties without structural simplification of naturally occurring alkaloids. Three distinct modes of [4+2] cyclizations and two types of redox-mediated annulations provided divergent access to five skeletally distinct scaffolds involving iboga-, aspidosperma-, andranginine-, and ngouniensine-type skeletons and a non-natural variant within 6-9 steps from tryptamine. The efficiency of our approach was demonstrated by successful total syntheses of (±)-vincadifformine, (±)-andranginine, and (−)-catharanthine. Natural products often bear a variety of functional groups on a rigid, architecturally complex, and sp 3 -rich skeleton, which allows specific molecular recognition through multi-point interactions to modulate the functions of target biomacromolecules. Chemical synthesis of natural products and their analogs could provide optimum screening collections for the development of drug candidates
with higher hit rates and a lower probability of side effects. [1] [2] [3] While some innovative synthetic approaches have been recently reported to gain efficient access to such molecules as specific modulators of challenging biological targets, [4] [5] [6] [7] [8] [9] [10] [11] a potentially general strategy for the development of divergent synthetic process to produce assortments of skeletally diverse and densely functionalized scaffolds remains unsettled and needs to be formulated.
In working toward the total synthesis of a natural product composed of complex cyclic arrays, chemists usually develop a customized synthetic approach for the individual targeted scaffold. In contrast, biosynthetic machinery often exploits a common intermediate, conducting divergent transformations to furnish assortments of architecturally distinct skeletons. For instance, a biogenetic hypothesis for monoterpene indole alkaloids is outlined in Fig. 1 . 12 Multistep enzymatic transformations commence with the assembly of tryptamine (1) and secologanin (2) to produce preakuammicine (3) . Cleavage of two C-C bonds in the central core of 3 generates the hypothetical key intermediate dehydrosecodine (4) , composed of a pair of diene units, a dihydropyridine (DHP), and a vinylindole. The intermediate (4) may undergo divergent Diels-Alder-type reactions in either of two ways, with the DHP group serving as a dienophile or diene to form the aspidosperma-type alkaloid tabersonine (5) (path A) or the iboga-type catharanthine (6) (path B). 13 In addition, a distinct biosynthetic [4+2] cyclization is postulated for andranginine (7) (path C), involving an intermediate bearing a cross-conjugated triene with a higher oxidation level than 4. 14 In the biosynthetic assembly line, the protection of the labile intermediates in an enzyme catalytic site provides kinetic stabilization and regulation of multimodal reactivity, allowing cascade synthesis with control of chemo-, regio-, stereo-, and even enantioselectivity. In principle, each evolved enzyme possesses a tailored fit that contributes to the catalysis of a particular mode of a skeleton-constructing transformation; 16 hence, the participation of a series of similar but functionally distinct biomacromolecular catalysts is required for skeletal diversification. Meanwhile, chemical emulation of divergent biogenic processes without the assistance of biomolecular catalysts 17 pose challenges, including (I) stabilization of the labile intermediates during handling in laboratory, (II) concise and flexible assembly of building blocks, and (III) systematic implementation of various intramolecular cyclization reactions through site-selective activation of polyunsaturated substrates while suppressing competitive reactions. In this study, we aimed to formulate a chemical strategy not only to build a bioinspired assembly line but also to achieve systematic diversification of the skeletal and stereochemical properties of multicyclic scaffolds without structural simplification of the natural products involved. Herein, we report the successful development of a divergent synthetic process, which generates unprecedented levels of skeletal variation of monoterpene indole alkaloids.
Figure 2 | Outline of a biogenetically inspired synthetic process to furnish alkaloidal scaffolds. a,
Synthetic strategy for a divergent process featuring reactivity modulation of an achiral poly-unsaturated intermediate (14) through manipulation of the carbonyl group conjugated with the dihydropyridine (DHP) unit. Modular assembly of tryptamine (1) and building blocks (9, 10 and 12) followed by cyclization of ene-yne (13) would allow rapid and flexible access to the common intermediate (14) . Three distinct modes of bioinspired [4+2] cyclizations could produce assortments of naturally occurring scaffolds (15−17) . Distinct modes of annulations were devised through redox-activations of the DHP unit to furnish either the tetracyclic framework (18) of ngouniensine or the unnatural skeleton (19) . b, Rapid formation of 1,6-DHP ring using Cu(I) catalysis. The optimum conditions for the 6-endo cyclization of ene-yne were explored using the model substrate (20) . dppf, 1,1'-bis(diphenylphosphino)ferrocene.
Results and discussion
Design of the divergent synthetic process. To explore a biogenetically inspired synthetic approach, we first considered the dehydrosecodine (4) . Unfortunately, the hypothetical intermediate (4) has not been isolated or synthesized, presumably because the DHP unit of 4, containing an ethyl substituent, may be labile to oxidation and oligomerization. In this study, we designed the artificial pluripotent intermediate (14) with intention of stabilizing the polyunsaturated system and thus installed an electron-withdrawing carbonyl group in place of the ethyl substituent ( Fig. 2a ). In addition, the attachment of various substituents to the carbonyl group could modify the reactivity of the DHP unit for systematic implementation of intramolecular cyclizations with control of regio-and stereoselectivity. We devised three types of bioinspired [4+2] cyclizations of 14, leading to 15-17, by manipulating the DHP unit conjugated with the carbonyl group. Moreover, redox activations of the DHP unit of 14 were explored to achieve distinct modes of annulations to furnish either the tetracyclic framework (18) of ngouniensine (8) 18 or the unnatural skeleton (19) . We also conceived a late-stage chiral induction by attaching an auxiliary to the carbonyl group to accomplish enantioselective synthesis.
The sensitive DHP unit in the intermediate (14) should be formed just prior to the divergent cyclization reactions. Retrosynthetically, chemoselective activation of the alkynyl group in ene-yne (13) would allow 6-endo cyclization to afford 14. With the intention of flexibly incorporating a series of enaminocarbonyl moieties into the precursors, we devised a union of a tricyclic precursor (11) with an ethynylcarbonyl compound (12) , accompanied by Hofmann elimination, to generate the ene-yne (13) containing a vinylindole unit. The precursor (11), a β-amino acid derivative, should be readily available by assembly of tryptamine (1) with methyl 3-bromo-2-oxopropanoate (9) and propargyl bromide (10) .
Development of Cu(I)-catalyzed cyclization to form the DHP ring. With this strategic planning
in mind, we first sought to develop an expedient protocol for the conversion of ene-yne (13) to the DHP-vinylindole intermediate (14) (Fig. 2b) . Whereas approaches to the synthesis of substituted pyridines via oxidation of temporarily formed DHPs have been relatively well explored, [19] [20] [21] protocols for obtaining DHP rings via metal-catalyzed 6-endo cyclization of N-propargyl enaminocarbonyls are limited. 22, 23 In our system, rapid construction of the 1,6-DHP ring was required under very mild conditions without causing further intra-and intermolecular reactions of the elaborate π-conjugated systems in 14. As shown in Fig. 2b , investigation using the model substrate (20) allowed us to identify the optimum conditions that employ a cationic Cu(I) catalyst as an efficient alkyne activator. Upon treatment of 20 with a catalytic amount (10 mol%) of [Cu(dppf)(MeCN)]PF 6 24 in dichloromethane, 6-endo cyclization proceeded smoothly within 60 min at room temperature to afford the desired 1,6-DHP (21) in 97% yield without affecting the non-protected indole or the resulting DHP ring located in the vicinity. 
Synthesis of a precursor for DHP cyclization, ene-yne (13a).
Having developed a sensible approach to formation of the 1,6-DHP ring, we synthesized ene-yne (13a), bearing a vinylindole unit, from tryptamine (1) in 5 steps ( Fig. 3) . A Pictet-Spengler reaction of 1 with 9 and subsequent ring expansion gave 22, based on a reported protocol. 25 . It is likely that the contribution of hydrogen bonding between the indole NH and the carbonyl oxygen of the α,β-unsaturated methylester in 14a not only increased the electrophilicity of the dienophile but also fixed the conformation appropriately for cyclization to form the iboga-skeleton (23) .
Next, we aimed to achieve a distinct mode of [4+2] cyclization leading to the aspidosperma-skeleton (25) (Fig. 3) . Despite extensive efforts to activate 14a with various Lewis/Brønsted acids and bases, formation of the iboga-skeleton (23) and oxidation to pyridinium salts occurred predominantly. The aspidosperma-skeleton (25a) was obtained, in less than 5% yield, only when 14a was carefully treated with tert-butyldimethylsilyl trifluoromethanesulfonate Redox-mediated cyclization reactions leading to 28 and 29. Further skeletal diversifications were then explored through redox activation of the DHP unit ( Fig. 4) . To achieve an alternative cyclization of 14a, we first envisaged two-electron oxidation of the DHP ring to generate a pyridinium species.
Indeed, when the reaction mixture for the conversion of 13a to 14a was heated to 120 °C, a distinct annulation of 14a took place predominantly, giving tetracyclic scaffold (28) in good yield (57% from 11a). The tetracyclic array of 28 is identical to the framework of naturally occurring ngouniensine (8) . 27 The relative configuration of 28 was elucidated based on X-ray analysis of the crystalline equivalents (see Supporting Information). Taking into account for the experimental results on the conversions of deuterium labeled 14a (see Supplementary Schemes S1-S2), 28 could presumably be formed through a hydride shift generating a zwitterionic intermediate composed of a pyridinium cation and an enolate anion, which would undergo subsequent 7-endo cyclization. 28 In contrast to the identical conversion of 13a into 14a under gentle heating at 60 °C, yielding the iboga-skeleton (23) as the major product ( Fig. 3) , 23 was not obtained at all at 120 °C. We thus postulated the involvement of a retro-Diels-Alder reaction. When isolated 23 was heated to 120 °C, as expected, we observed the consumption of 23 and the formation of 28 as the major product (47%, see Supporting Information). It seems probable that the retro-Diels-Alder reaction of kinetically formed 23
regenerates the DHP-vinylindole intermediate (14a) at the elevated temperature. Hydride transfer and subsequent cyclization may occur irreversibly to furnish ngouniensine-type scaffold (28) . Single-electron oxidation of 14a provided an unnatural-type scaffold (29) presumably via 8-endo-radical cyclization. bpy, 2,2'-bipyridine; dppf, 1,1'-bis(diphenylphosphino)ferrocene.
Next, we envisioned single-electron oxidation of the 1,6-DHP ring in 14a to generate a carbon-centered radical species. Since photo-redox synthetic processes often employ (29) , not found in naturally occurring alkaloids, was obtained, albeit in low yield (21%), which may have been consistent with our intention to conduct a redox-mediated 8-endo cyclization. Oxidative activations of 14a in either a two-electron or a single-electron process produced the tetracyclic scaffolds (28 and 29) bearing DHP ring in their fused scaffolds, which could provide a versatile platform for further diversification. In this way, we illustrated the systematic generation of skeletally diverse scaffolds (23, 25, and 27-29 ) relevant to naturally occurring indole alkaloids within 6-9 steps from tryptamine (1) .
Total synthesis of three natural products. To highlight the applicability and efficiency of the divergent synthetic process, we sought to achieve total syntheses of (±)-vincadifformine (32), (±)-andranginine (7) , and (−)-catharanthine (6) (Fig. 5 ). Since the aspidosperma-type scaffold (25b) bears the requisite functional array of (±)-vincadifformine (32) (Fig. 5a ), we carried out a total synthesis to confirm its structure (see Supporting Information for precedent total syntheses of 32). 5, [32] [33] [34] [35] The more sterically hindered methyl ester in 25b was reduced site-selectively by simple treatment with diisobutylaluminium hydride (DIBAL) to furnish primary alcohol 30 in 87% yield.
Oxidation of 30 and subsequent Wittig elongation produced 31, which contains a vinyl group.
Site-selective hydrogenation of 31 gave rise to (±)-vincadifformine (32) in 77% yield. Site-selective hydrogenation of 31 afforded (±)-vincadifformine (32) . b, Direct conversion of silylenol ether (27) to vinyl triflate (33) and subsequent palladium-catalyzed reduction furnished (±)-andranginine (7) . c, Hofmann elimination triggered by addition of 11a to 12c gave 34. After Cu(I)-catalyzed formation of DHP ring, the critical [4+2] cyclization reaction proceeded with complete diastereocontrol in one-pot to produce 35. Removal of the chiral auxiliary, site-selective reduction of 36, and conversion into an allylic phosphate (37) followed by Fe-catalyzed cross-coupling with MeMgBr accomplished asymmetric total synthesis of (−)-catharanthine (6) . DIBAL, diisobutylaluminium hydride; NaHMDS, sodium hexamethyldisilazide; Tf, trifluoromethanesulfonyl; dppf, 1,1'-bis(diphenylphosphino)ferrocene; acac, acetylacetonate.
Next, the conversion of pentacycle (27) to (±)-andranginine (7) was accomplished by trimming an additional functional group in two steps (Fig. 5b) . Direct conversion of 27 bearing a silylenol ether to vinyl triflate (33) 36 and subsequent palladium-catalyzed reduction furnished 7 in good yield. X-ray analysis of crystalline 7 confirmed its relative configuration, which was identical to the proposed structure of andranginine. 37 This is the first example of de novo total synthesis of the almost disregarded natural product, (±)-andranginine (7) , in 11 steps, 38 which lends experimental support to an alternate mode of biosynthetic Diels-Alder-type cyclization diverging from the hypothetical intermediate (4) .
We then performed enantioselective total synthesis of catharanthine (6) (Fig. 5c ). To illustrate late-stage asymmetric induction through attachment of a chiral auxiliary to the DHP ring, ene-yne an allylic alcohol, which was then transformed to an allylic phosphate (37) in good yield. An iron-catalyzed cross-coupling reaction with methyl Grignard reagent 39 proceeded regioselectively accomplishing asymmetric total synthesis of (−)-catharanthine (6) . The absolute configuration was assigned based on optical rotation (see Supporting Information). While there has been pioneering synthetic studies, 26,40-49 the 10-step sequence described herein is the shortest enantiocontrolled total synthesis of (−)-catharanthine (6) , to the best of our knowledge. 50 Consequently, we have successfully demonstrated that the appropriately functionalized scaffolds generated via three distinct modes of the bioinspired [4+2] cyclizations are readily applicable for achieving total syntheses of (±)-vincadifformine (32), (±)-andranginine (7) , and (−)-catharanthine (6) .
In summary, we have developed a unified synthetic process generating unprecedented levels of scaffold variations of natural products without structural simplification. The multipotent DHP-vinylindole intermediates (14a-c) were flexibly synthesized through unions of tricycles (11a-c) and ethynylcarbonyl units (12a-c) followed by Cu(I)-catalyzed formation of the DHP ring.
By harnessing the versatile reactivity of 14, multiple modes of annulation were systematically implemented. The divergent process allowed a concise and programmable access to four naturally occurring scaffolds (23, 25b, 27, and 28) followed by cyclization of ene-yne (13) would allow rapid and flexible access to the common intermediate (14) . Three distinct modes of bioinspired [4+2] cyclizations could produce assortments of naturally occurring scaffolds (15−17) . Distinct modes of annulations were devised through redox-activations of the DHP unit to furnish either the tetracyclic framework (18) of ngouniensine or the unnatural skeleton (19) . b, Rapid formation of 1,6-DHP ring using Cu(I) catalysis. The optimum conditions for the 6-endo cyclization of ene-yne were explored using the model substrate (20) . dppf, 1,1'-bis(diphenylphosphino)ferrocene. Single-electron oxidation of 14a provided an unnatural-type scaffold (29) presumably via 8-endo-radical cyclization. bpy, 2,2'-bipyridine; dppf, 1,1'-bis(diphenylphosphino)ferrocene. Site-selective hydrogenation of 31 afforded (±)-vincadifformine (32) . b, Direct conversion of silylenol ether (27) to vinyl triflate (33) and subsequent palladium-catalyzed reduction furnished (±)-andranginine (7) . c, Hofmann elimination triggered by addition of 11a to 12c gave 34. After Cu(I)-catalyzed formation of DHP ring, the critical [4+2] cyclization reaction proceeded with
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